Difficulty: Medium
Average Score: 92%
Practice
A nurse is reviewing a laboratory report for a client who is at 33 weeks of gestation and has preeclampsia. Which of the following laboratory results should the nurse report to the provider?
Correct answer
A
Rationale
In this scenario, the correct answer is option A) BUN 35 mg/dL, which the nurse should report to the provider. In preeclampsia, renal function can be affected, leading to impaired clearance of waste products by the kidneys. Elevated BUN (blood urea nitrogen) levels can indicate decreased kidney function, which is a concern in a client with preeclampsia. This finding could suggest worsening kidney function and the need for further evaluation and management.
Options B, C, and D are not the most critical values to report in a client with preeclampsia at 33 weeks of gestation. Option B, Hgb 15 mg/dL, represents the hemoglobin level, which is typically not a primary concern in the context of preeclampsia unless it is severely low. Option C, Bilirubin 0.6 mg/dL, is within the normal range and is not typically a priority in the management of preeclampsia. Option D, Hct 37%, represents the hematocrit level, which may be elevated due to hemoconcentration in preeclampsia but is not as concerning as the elevated BUN level indicating possible renal involvement.
Educationally, understanding the significance of laboratory values in the context of specific conditions like preeclampsia is crucial for nurses caring for pregnant clients. Recognizing abnormal values and knowing which ones are priorities for reporting can help ensure timely intervention and optimal outcomes for both the mother and the baby. Regular monitoring and prompt reporting of changes in laboratory values are essential components of high-quality maternal-newborn care.
Options B, C, and D are not the most critical values to report in a client with preeclampsia at 33 weeks of gestation. Option B, Hgb 15 mg/dL, represents the hemoglobin level, which is typically not a primary concern in the context of preeclampsia unless it is severely low. Option C, Bilirubin 0.6 mg/dL, is within the normal range and is not typically a priority in the management of preeclampsia. Option D, Hct 37%, represents the hematocrit level, which may be elevated due to hemoconcentration in preeclampsia but is not as concerning as the elevated BUN level indicating possible renal involvement.
Educationally, understanding the significance of laboratory values in the context of specific conditions like preeclampsia is crucial for nurses caring for pregnant clients. Recognizing abnormal values and knowing which ones are priorities for reporting can help ensure timely intervention and optimal outcomes for both the mother and the baby. Regular monitoring and prompt reporting of changes in laboratory values are essential components of high-quality maternal-newborn care.